Teladoc (TDOC) shares are inching up after Citron Research likened them to a “coiled spring” – full of potential, compressed, ...

I maintain my Buy rating on Teladoc Health due to positive acquisitions and a robust balance sheet, despite recent weak Q1 ...

Teladoc (TDOC) shares rallied 14.4% in the last trading session to close at $7.89. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session ...

Teladoc Health Inc (NYSE:TDOC) shares are rising Monday after Citron Research made positive comments about the company on its ...

Teladoc Health stock price surged by over 14% on Monday, its best single-day gain since April 9. What next for the TDOC share ...

Teladoc Health (TDOC) stock rallies as Citron Research issues a bullish report on the company. Read more here.

TDOC has not said where and when the drug pentobarbital was purchased. Tennessee has paid nearly $600,000 for lethal injection drugs in recent years, but the details are shrouded in secrecy.

The Tennessee Department of Correction announced the launch of a digital mail delivery pilot program at three facilities ...

The latest trading session saw Teladoc (TDOC) ending at $7.40, denoting a +1.79% adjustment from its last day's close. The stock's change was more than the S&P 500's daily gain of 0.09%. The ...

But TDOC again canceled its procurement when Centurion filed a protest. The letter from the state's Central Procurement Office sent March 18 explained the cancellation by merely stating, ...

Teladoc (TDOC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ...